ARTICLE | Clinical News
Jasco Pharmaceuticals preclinical data
April 15, 2013 7:00 AM UTC
In an animal xenograft model of MM, twice-daily 30 mg/kg oral JP-11646 inhibited tumor growth by 82% vs. vehicle-treated controls. In MM cell lines with chromosome translocations known for poor progno...